CLINICAL_TRIALS
trial_result
· 2016-10-07
Clinical Trial Update: Topical Sirolimus for the Treatment of Pachyonychia Congenita (PC) [Phase 1]
Summary
This Phase 1 trial evaluated topical sirolimus for pachyonychia congenita. The study is completed and results were posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: TransDerm, Inc. | Conditions: Pachyonychia Congenita | Phase 1 | Status: COMPLETED | Results posted: 2016-10-07